Back to News
Market Impact: 0.4

Stocks making the biggest moves midday: Lucid Group, Elevance Health, Albemarle, PepsiCo & more

SHOOLCIDUBERELVMCRIFDSSAHGPIJPMALBPEPTSMGEUSBCARSTOSTUALADMKOSRPTABTSHAK
Corporate EarningsAnalyst InsightsAnalyst EstimatesCorporate Guidance & OutlookCompany FundamentalsM&A & RestructuringTechnology & InnovationAutomotive & EV
Stocks making the biggest moves midday: Lucid Group, Elevance Health, Albemarle, PepsiCo & more

Midday trading saw significant equity movements driven by diverse catalysts including earnings, analyst actions, and strategic news. Lucid Group surged 31% following a major EV deployment deal, while Monarch Casino & Resort and Taiwan Semiconductor Manufacturing also posted strong gains on robust Q2 earnings. Conversely, Elevance Health tumbled 16% due to an earnings per share miss, and auto retailers Sonic Automotive and Group 1 Automotive declined after JPMorgan downgrades. Other notable movers included Albemarle, which rose as Chinese government action boosted lithium prices, and Sarepta Therapeutics, which gained on a strategic workforce reduction aimed at cost savings, reflecting a dynamic market reacting to company-specific and broader industry developments.

Analysis

Midday trading activity reveals a market driven by company-specific catalysts rather than a single macroeconomic trend, with significant divergence in performance across sectors. Strategic announcements proved to be a powerful driver, exemplified by Lucid Group's 31% surge following its 20,000-vehicle deployment deal with Nuro and Uber, and Sarepta Therapeutics' 19% gain after announcing a restructuring expected to yield $120 million in annual cost savings. Strong Q2 earnings reports also fueled substantial gains, with Monarch Casino & Resort jumping 19% on a 19% year-over-year net income increase and an EPS of $1.44 that beat the $1.20 consensus. Similarly, Taiwan Semiconductor rose 4% after its profit grew 61% to a record high, and GE Aerospace advanced 2% on an earnings beat and raised full-year guidance. Conversely, earnings misses and weak outlooks were heavily penalized. Elevance Health tumbled 16% after its EPS of $8.84 missed the $8.95 estimate, while Abbott Laboratories slid 8% on a third-quarter guidance that fell short of expectations. Analyst actions also directly influenced stock prices; JPMorgan's downgrades of Sonic Automotive and Group 1 Automotive triggered respective declines of 9% and 7.5% due to valuation concerns, while a Citi upgrade lifted Steven Madden by over 5%.